Abstract The aim of the present study is to evaluate, for the first time, antigenotoxic potential of Agaricus bisporus against methyl methanesulphonate induced toxicity in human lymphocyte culture in vitro and in bone marrow cells of albino mice in vivo. The parameters studied included total aberrant cells and the frequencies of aberrations in the bone marrow cells at three exposure durations viz., 16, 24 and 32 h, and for the in vitro method using chromosomal aberrations, sister chromatid exchanges and replication indices as markers. The alcoholic extract of A. bisporus was taken in five increasing concentrations of 200, 250, 300, 350 and 400 mg/kg body weight for three in vivo exposure durations viz., 16, 24 and 32 h. Similarly, four doses of extracts viz., 150, 200, 250 and 300 lg/ ml of culture were taken for in vitro durations of 24, 48 and 72 h in the presence as well as the absence of S 9 -mix. The treatment reduced the total number of aberrant cells ranging from 10.0% to 46.15% and it reduced the total frequencies of aberrations ranging from 198 to 96 against very high aberrations i.e., 227 caused due to methyl methanesulphonate in vivo. The same trends were observed in the in vitro experiments i.e., it reduced chromosomal aberrations from (42.00%, 71.25%, and 83.00% to 20.00%, 39.50%, and 43.00%) at 24, 48, and 72 h of exposure respectively.
However when experiments were carried out in the presence of liver S 9 fraction, these values were respectively 52.38, 44.56, and 48.34% significant at <0.05 level, likewise it also reduced sister chromatid exchanges from 14.86 ± 1.44 down to 8.84 ± 0.75 per cell, whereas the replication index got enhanced from 1.45 to 1.64.
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Introduction
Dietary mushrooms have been used globally since millennia to promote health and prevent and treat various diseases due to their multitude of medicinal qualities [1] . The number of different mushroom species on earth is estimated at 140,000 of which only 10% is known [2] . In general, medicinal dietary mushrooms have been shown to improve cardiovascular health, stimulate immune function and contribute to glucose homeostasis and to modulate detoxification, as well as exert anti-allergic, antiviral, antibacterial, antifungal and antiinflammatory activities [3] .
The use of mushrooms with potential therapeutic properties has greatly raised global interest in the scientific as well as clinical community based on two main reasons. Firstly, mushrooms demonstrate their efficiency against numerous diseases including metabolic disturbances as serious as cancer and degenerative diseases. Secondly, these therapeutic effects seem to encompass multiple complex pharmacological actions on different cellular and molecular targets [4] . The most significant medicinal effects of mushrooms and their metabolites that have attracted the attention of the public are their antitumor properties [5, 6] . The medicinal use of edible mushroom extracts seems to be more of a natural and less expensive approach and, in general, involves minimal unwanted side effects. Moreover, purified bioactive compounds derived from edible mushrooms might be potentially important new sources of anticancer agents. It has been known for many years that selected mushrooms of higher basidiomycetes origin are effective against certain types of cancer which have stirred a great interest in the use of such mushrooms across industry, media and the scientific community [2] .
In recent years, multiple drug resistance in human pathogenic microorganisms has been reported to indiscriminate the use of commercially used antimicrobial drugs for the treatment of infectious diseases. Extracts from fruiting bodies and the mycelia of various mushrooms have been reported to cause antimicrobial activity against a wide range of infectious bacteria [7] .
Materials and methods
The whole plant of A. bisporus was dried in the shade at room temperature. The shade dried plants were powdered and 60 g of coarse powder was defatted with petroleum ether and extracted exhaustively with 95% methanol at a temperature of 60°C. The extract was dried by a vacuum evaporator. Methanolic extract of A. bisporus was dissolved in dimethyl sulphoxide (DMSO) to prepare different optimum concentrations for studies following earlier methodology [8] .
In vivo method
Albino mice 8-10 weeks old (25-35 gm in weight) were exposed to different test chemicals by appropriate routes (intra peritoneal i.e., I.P injection) and were sacrificed at sequential intervals of 16, 24 , and 32 h of stipulated treatment time. Animals were treated with each test substance as shown in the tables (Table A) . Further processes of slide preparations, cells and chromosomal aberrations analyses are adopted from earlier published work [8] .
The reduction factors due to test chemical treatments were calculated using the formula: 
In vitro lymphocytes culture method
Human peripheral blood lymphocytes are extremely sensitive indicators of the in vitro assay system. The chromosomal changes (numerical and structural) were utilized for investigation of the genotoxic as well as antigenotoxic potentiality of test chemicals. The parameters studied included chromosomal aberrations (CA), sister chromatid exchanges (SCEs) and cell growth kinetics (RI) both in the presence and in the absence of the exogenous metabolic activation system. The in vitro culture methods, preparation of S 9 (microsomal fraction), media preparation and analyses of chromosomal aberrations, sister chromatid exchanges, cell cycle kinetics and statistical analysis were followed as per earlier methodology. [8] The replication index (RI) was calculated according to the formula of Tice et al. [9] as given below. The deviation from the controls was determined by using the Chi-square (v 2 ) test.
Results

In vivo effects
The results following the treatment of A. (Fig. 1) . The total numbers of frequency in the aberrant cells were 198 for MMS alone, whereas the same were 206, 169, 146, 138 and 124 in numbers for five different doses of A. bisporus extract respectively. The reduced values are statistically significant in comparison to MMS alone. As the doses of A. bisporus extract increases, the total frequency decreases, thus it shows a dose-dependent relationship. Cells with five or more aberrations were very few in numbers. A similar trend was obtained after 24 h of treatments. The obtained value of percent aberrant cells was 13.0% for MMS and 11.0%, 9.0%, 8.0%, 7.9% and 7.0% for five different concentrations of A. bisporus extract along with MMS. The percent reductions in the aberrant cells were 15.38%, 30.76%, 38.46%, 39.23% and 46.15% which shows very significant effect of different concentrations of the extract. It showed a dose dependent relationship between the doses of the extract and percentage reduction of the aberrant cells (Table 1 Fig. 1 ). The frequency of aberrant cells was recorded ( Table 2) . The values recorded were 222 aberrations for MMS and 145, 132, 107, 110 and 96 aberrations for the extracts plus MMS. The trends of reductions were dose dependent for the extracts (Table 2) .
After 32 h of experiments the value obtained for the total number of aberrant cells was 151 for MMS alone while this number gets reduced to 140, 130, 110, 94 and 86 for their respective increasing concentrations of A. bisporus extract given with MMS. In terms of percent reductions in the number of aberrant cells, the extract showed a very much effective action in reducing the aberrant cells. The values for five concentrations of A. bisporus extract were 07.28%, 13.90%, 27.54%, 37.08% and 43.00% as shown in Fig. 1 . The total frequency of aberrations followed a similar trend. The values recorded were 227 aberrations for MMS and 198, 171, 145, 119 and 119 aberrations for the extracts plus MMS.
In vitro effects
All the cultures were treated with Methyl methanesulphonate (MMS) at three different durations viz., 24, 48 and 72 h. The results of the treatment obtained in terms of clastogenic abnormalities in percent metaphase aberration, types of aberrations and aberrations per cell respectively are as follows viz., 40.00%, 58.50%, 69.75% and 0.40%, 059%, 0.70% aberrations calculated per cell respectively, while the control values for normal and DMSO plus A. bisporus extracts are 3.50, 4.75 percent at single standard doses at three different durations viz., 24, 48 and 72 h. The A. bisporus extract brings down aberrations from 40.00% to 32.00%, 27.75%, 23.25% and 21.00% with four consecutive doses at 24 h of duration, whereas at 48 h, it got lowered from 58.50% to 52.00%, 45.25%, 41.75% and 37.25% respectively by Ist to 4th concentrations of A. bisporus extracts. The same trend was noticed, when the treatment durations were increased to 72 h. These values show linear increasing trends with duration and doses of extracts. The maximum percentage reductions in the aberrations were 47.50% for 24 h and 36.32% and 42.65% for 48 and 72 h respectively, obtained due to the highest doses of A. bisporus extracts (Fig. 2) .
Similarly when the experiment was setup along with the metabolic activation system (+S 9 mix), the effect of MMS got increased. The effect of the A. bisporus extract also showed similar increasing antigenotoxic trends as they lowered the clastogenic activity of MMS. The values showed linear increase with dosages (Table 3 and Fig. 3 ). The maximum effective percentage reductions were 52.38%, 44.56% and 48.35% for 24, 48 and 72 h respectively. The highest reduction for clastogeny of cells was noticed at 24 h durations; though the other values were also statistically significant at P < 0.05 level.
The data obtained from the experimental setup for sister chromatid exchanges are indicated in Table 4 and show a reduction in SCE in the absence as well as in the presence of the metabolic activation system; there was a lowering of the mean range and of the total SCEs and SCE per cell from 13.30 to 07.60 and from 14.86 to 8.84 . For the analysis of SCE, only 48 h cultures were used and only 50 metaphases were scanned (Fig. 4) .
The effects of A. bisporus extract on the replication index are shown in Table 5 and seem to elevate the level of the index when compared to the MMS treatment alone i.e. from 1.46 to 1.67; (though still lower than the normal level of 1.76). After being treated with the metabolic activation system, it was enhanced from 1.40 to 1.61. The A. bisporus extract, therefore, Figure 1 Shows in vivo anticarcinogenic effect of Agaricus bisporus extracts at 16, 24, and 31 h of treatment durations against MMS genotoxicity in albino mice bone marrow cell (significant at P < 0.05 level). is an effective anti-clastogenic agent as observed by these experiments.
Discussion
The role of phenolic compounds in acting as scavengers of free radicals is widely reported [10] ; phenolic compounds play a major role in antioxidant activities shown by many vegetables [11] . It is suggested that polyphenolic compounds have inhibitory effects on mutagenesis and carcinogenesis in humans, when ingested daily from a diet rich in fruits and vegetables [12] . In a study, performed with A. bisporus, it was thought that the high free radical-scavenging activity and total antioxidant activity may result from the existence of the phenolics and the flavonoids. The activity of ingredients against HL60 cells shows antiproliferative property, though there have been a number of reports which show that basidiomycetes have antitumor activity including antioxidant defense for the host immune system potential [13] . Many reports indicate that most of the polysaccharides or polysaccharide protein complexes from mushroom and natural sources cause direct cytotoxic effects on tumor cells, mainly through host mediated immune response, this type of inhibitory action may be interwoven and the mechanism of action may vary from person to person as also the type of cancer [14] . Ergosterol, a phenolic compound extracted from the white button mushroom, shows the inhibitory effect on breast cancer cell line in vitro by aromatase inhibition without side effects [15] .
A frequently reported protective mechanism exerted by mushrooms against cancer is the capacity to stimulate the immune system response where b-glucan, a water-soluble polysaccharide, is presumed to activate certain immune cells and the proteins that attack cancer, including macrophages, T-cells, natural killer cells, and interleukin-1 and interleukin-2 [2, 16] . Dietary mushrooms such as A. bisporus have also been shown to alter aromatase activity, an enzyme that is involved in the conversion of androgens to proliferative estrogenic intermediates, which are closely linked to breast cancer development [17] . Mushroom extracts contain other components such as lentinan and lectins, which are directly cytotoxic and cytostatic to tumor cells such as MCF-7 breast cancer cells [18] ) A. bisporus also contains bioactive antioxidants and anticarcinogenic substances including ergothioneine, selenium and polyphenols. Furthermore, studies have indicated that non-polysaccharide constituents in mushrooms have biological activity against murine skin cancer and human prostate carcinoma cells [19] . Collectively, there are many bioactive agents in mushrooms that can exert beneficial effects acting co-operatively in systems with different cell types, i.e. immunity, or exhibit cytotoxicity directly on the cancer cells.
Many diverse species of mushrooms and their respective bioactive agents have also demonstrated the capacity to inhibit cellular proliferation of human breast cancer cells in vitro. Isolated lectins from Pholiata adipose and Inocybe umbrinella exert strong antiproliferative activity toward MCF-7 and HepG2 human hepatoma cells with IC 50 in the range of 1.9-7.5 lmol/ L [20, 21] ). An isolated A. bisporus, or WB, lectin inhibits the incorporation of 3 H-thymidine into DNA by as much as 50% in MCF-7 cells and by 87% in HT29 colon cancer cells, about 16% in Caco-2 colon cancer cells, and by 55% in rat mammary fibroblasts (after 24 h incubation). This is in agreement with our observations since we have noted 33% reduction in BrdU incorporation after 24 h of incubation using in vitro human lymphocyte cultures. Numerous species of mushrooms when delivered as whole mushroom extracts or their isolated bioactive components, and their metabolites, can inhibit cellular proliferation, suggesting that this is a key mechanism of action.
There have been many mechanisms proposed for the inhibitory action of mushrooms including that of the immune system and boosting the cell signaling inhibition. For example, studies show that shiitake has tumor-inhibitory effects on proliferation possibly through reduction in natural killer cell cytotoxicity in rodent studies [22] . In a study, it was confirmed that OYS mushroom extracts potently inhibit proliferation by inducing cell cycle arrest at the G 0 /G 1 phase in MCF-7 cells [6] . Alternately, an extract of A. blazei inhibits cell growth in a dose-dependent manner through the arrest of cells in the G2/M phase and induction of apoptosis [23] . This is consistent with our results where proliferation was not altered as indicated by the replication index (RI) cell counts, though DNA replication clearly was decreased, suggesting an effect on the cell cycle. During the G 1 to S transition, cells are recruited for cellular proliferation through DNA replication, however if cells are arrested at this checkpoint, viz. G 0 /S, then DNA replication will get reduced or even prevented. Our results thus indicate a $30% reduction by the test of mushrooms on mutagenesis, as measured by BrdU incorporation, indicative of a block in DNA replication.
It was demonstrated that Pleurotus ostreatus induces G 0 /G 1 cell cycle arrest of MCF-7 cells by the up-regulation of the expression of p53 and p21, whereas cell cycle arrest of HT-29 is induced at G 0 /G 1 by the up-regulation of the expression of p21 [24] . Deregulated cell cycle progression is a common abnormality observed in human cancers. Progression through the cell-division cycle is regulated by the coordinated activities Table 4 Analysis of sister chromatid exchanges (SCE) after treatment with Methyl methanesulphonate along with Agaricus bisporus (AB) extract in vitro, in the presence of S 9 mix. Figure 4 Antigenotoxic effect of Agaricus bisporus extracts on sister chromatid exchanges in the absence as well as in the presence of a metabolic activation system. Total 50 metaphase plates were scored at 48 h of treatment durations (significant at P < 0.05 level). of cyclin/cyclin-dependent kinases (CDK) complexes. One level of regulation of these cyclin-CDK complexes is provided by their binding to CDK inhibitors (CKIs) [25] . In a study it was observed, using cDNA microarray technology and Western blot analysis, P. ostreatus up-regulated the expression of p21 and p53 in MCF-7 cells which had wild-type p53 [26] . Thus, treatment of MCF-7 cells by P. ostreatus may lead to the induction of p21 by p53 dependent mechanisms in MCF-7 cells. The increase of p53 protein levels in MCF-7 cells treated with P. ostreatus suggests that its inhibitory properties for growth may involve the induction of DNA damage response. The C terminus of p21, containing its nuclear localization signal, binds to or inhibits PCNA, thereby blocking DNA replication [27] . In the study, it was demonstrated that P. ostreatus slightly decreased the protein level of PCNA in MCF-7 treated cells, which may also contribute to the decreased DNA synthesis. However, expression of PCNA in HT-29 treated cells was not affected by P. ostreatus [26] .
Conclusion
Alcoholic extracts of A. bisporus reduce the total aberrant cells ranging from 10.0% to 46.15% and it reduces the total frequencies of aberration from 198 to 96 against 227 aberrations caused due to MMS alone in vivo. The same trends were observed in the in vitro experiments i.e., it reduces chromosomal aberrations to 47.50% for 24 h and 36.32% and 42.65% for 48 and 72 h respectively; however when experiments were carried out in the presence of the liver S 9 fraction, these values are 52.38%, 44.56% and 48.35% respectively, being significant at <0.05 level, likewise it also reduces sister chromatid exchange from 14.86 to 8.84 per cell and enhances the replication index from 1.45 to 1.64.
Alcoholic extracts of A. bisporus significantly reduce the number of aberrant cells and the frequency of aberrations per cell at each concentration and duration of exposure in vivo; similarly it reduces chromosomal aberrations and sister chromatid exchange but enhances the replication index in vitro, both of which are statistically significant at <0.05 level.
